CFR 21 Part 806

更新时间:2023-07-09 06:23:02 阅读：评论：0

[Code of Federal Regulations]

[Title 21, Volume 8]

[Revid as of April 1, 2014]

[CITE: 21CFR806]

TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER H--MEDICAL DEVICES

PART 806	MEDICAL DEVICES; REPORTS OF CORRECTIONS AND REMOVALS

Subpart A--General Provisions

Sec. 806.1 Scope.

(a) This part implements the provisions of ction 519(f) of the Federal Food, Drug, and Cosmetic Act (the act) requiring device manufacturers and importers to report promptly to the Food and Drug Administration (FDA) certain actions concerning device corrections and removals, and to maintain records of all corrections and removals regardless of whether such corrections and removals are required to be reported to FDA.

(b) The following actions are exempt from the reporting requirements of this part:

(1) Actions taken by device manufacturers or importers to improve the performance or quality of a device but that do not reduce a risk to health pod by the device or remedy a violation of the act caud by the device.

(2) Market withdrawals as defined in 806.2(h).

(3) Routine rvicing as defined in 806.2(k).

(4) Stock recoveries as defined in 806.2(l).

[62 FR 27191, May 19, 1997, as amended at 63 FR 42232, Aug. 7, 1998]

双十一口号

Sec. 806.2 Definitions.

As ud in this part:

(a) Act means the Federal Food, Drug, and Cosmetic Act.

(b) Agency or FDA means the Food and Drug Administration.

(d) Correction means the repair, modification, adjustment, relabeling, destruction, or inspection (including patient monitoring) of a device without its physical removal from its point of u to some other location.

(e) Correction or removal report number means the number that uniquely identifies each report submitted.

(f) Human cell, tissue, or cellular or tissue-bad product (HCT/P) regulated as a device means an HCT/P as defined in 1271.3(d) of this chapter that does not meet the criteria in 1271.10(a) and that is also regulated as a device.

(g) Importer means, for the purpos of this part, any person who imports a device into the United States.

(h) Manufacturer means any person who manufactures, prepares, propagates, compounds, asmbles, or process a device by chemical, physical, biological, or other procedures. The term includes any person who:

(1) Repackages or otherwi changes the container, wrapper, or labeling of a device in furtherance of the distribution of the device from the original place of manufacture to the person who makes final delivery or sale to the ultimate ur or consumer;

(2) Initiates specifications for devices that are manufactured by a cond party for subquent distribution by the person initiating the specifications; or

(3) Manufactures components or accessories which are devices that are ready to be ud and are intended to be commercially distributed and are intended to be ud as is, or are procesd by a licend practitioner or other qualified person to meet the needs of a particular patient.

(i) Market withdrawal行测题型 means a correction or removal of a distributed device that involves a minor violation of the act that would not be subject to legal action by FDA or that involves no violation of the act, e.g., normal stock rotation practices.

(j) Removal means the physical removal of a device from its point of u to some other location for repair, modification, adjustment, relabeling, destruction, or inspection.

(k) Risk to health means

(1) A reasonable probability that u of, or exposure to, the product will cau rious adver health conquences or death; or

(2) That u of, or exposure to, the product may cau temporary or medically reversible adver health conquences, or an outcome where the probability of rious adver health conquences is remote.

(l) Routine rvicing means any regularly scheduled maintenance of a device, including the replacement of parts at the end of their normal life expectancy, e.g., calibration, replacement of batteries, and respons to normal wear and tear. Repairs of an unexpected nature, replacement of parts earlier than their normal life expectancy, or identical repairs or replacements of multiple units of a device are not routine rvicing.

(m) Stock recovery means the correction or removal of a device that has not been marketed or that has not left the direct control of the manufacturer, i.e., the device is located on the premis owned, or under the control of, the manufacturer, and no portion of the lot, model, code, or other relevant unit involved in the corrective or removal action has been relead for sale or u.

(n) Unique device identifier (UDI) means an identifier that adequately identifies a device through its distribution and u by meeting the requirements of 830.20 of this chapter. A UDI is compod of:

(1) A device identifier有恃无恐的意思 --a mandatory, fixed portion of a UDI that identifies the specific version or model of a device and the labeler of that device; and

(2) A production identifier --a conditional, variable portion of a UDI that identifies one or more of the following when included on the label of the device:逆商读后感

(i) The lot or batch within which a device was manufactured;

(ii) The rial number of a specific device;

(iii) The expiration date of a specific device;

(iv) The date a specific device was manufactured.

(v) For an HCT/P regulated as a device, the distinct identification code required by 1271.290(c) of this chapter.

年度工作目标

[62 FR 27191, May 19, 1997, as amended at 63 FR 42232, Aug. 7, 1998; 78 FR 55821, Sept. 24, 2013]

Subpart B--Reports and Records

Sec. 806.10 Reports of corrections and removals.

(a) Each device manufacturer or importer shall submit a written report to FDA of any correction or removal of a device initiated by such manufacturer or importer if the correction or removal was initiated:

(1) To reduce a risk to health pod by the device; or

(2) To remedy a violation of the act caud by the device which may prent a risk to health unless the information has already been provided as t forth in paragraph (f) of this ction or the corrective or removal action is exempt from the reporting requirements under 806.1(b).

(b) The manufacturer or importer shall submit any report required by paragraph (a) of this ction within 10-working days of initiating such correction or removal.

(1) The ven digit registration number of the entity responsible for submission of the report of corrective or removal action (if applicable), the month, day, and year that the report is made, and a quence number (i.e., 001 for the first report, 002 for the cond report, 003 etc.), and the report type designation "C" or "R". For example, the complete number for the first correction report submitted on June 1, 1997, will appear as follows for a firm with the registration number 1234567: 1234567-6/1/97-001-C. The cond correction report number submitted by the same firm on July 1, 1997, would be 1234567-7/1/97-002-C etc. For removals, the number will appear as follows: 1234567-6/1/97-001-R and 1234567-7/1/97-002-R, etc. Firms that do not have a ven digit registration number may u ven zeros followed by the month, date, year, and quence number (i.e. 0000000-6/1/97-001-C for corrections and 0000000-7/1/97-001-R for removals). Reports received without a ven digit registration number will be assigned a ven digit central file number by the district office reviewing the reports.

(2) The name, address, and telephone number of the manufacturer or importer, and the name, title, address, and telephone number of the manufacturer or importer reprentative responsible for conducting the device correction or removal.

(3) The brand name and the common name, classification name, or usual name of the device and the intended u of the device.

(4) Marketing status of the device, i.e., any applicable premarket notification number, premarket approval number, or indication that the device is a preamendments device, and the device listing number. A manufacturer or importer that does not have an FDA establishment registration number shall indicate in the report whether it has ever registered with FDA.

(5) The unique device identifier (UDI) that appears on the device label or on the device package, or the device identifier, universal product code (UPC), model, catalog, or code number of the device and the manufacturing lot or rial number of the device or other identification number.

(6) The manufacturer's name, address, telephone number, and contact person if different from that of the person submitting the report.

(7) A description of the event(s) giving ri to the information reported and the corrective or removal actions that have been, and are expected to be taken.

(8) Any illness or injuries that have occurred with u of the device. If applicable, include the medical device report numbers.

(9) The total number of devices manufactured or distributed subject to the correction or removal and the number in the same batch, lot, or equivalent unit of production subject to the correction or removal.

(10) The date of manufacture or distribution and the device's expiration date or expected life.

(11) The names, address, and telephone numbers of all domestic and foreign consignees of the device and the dates and number of devices distributed to each such consignee.

(12) A copy of all communications regarding the correction or removal and the names and address of all recipients of the communications not provided in accordance with paragraph (c)(11) of this ction.

(13) If any required information is not immediately available, a statement as to why it is not available and when it will be submitted.

(d) If, after submitting a report under this part, a manufacturer or importer determines that the same correction or removal should be extended to additional lots or batches of the same device, the manufacturer or importer shall within 10-working days of initiating the extension of the correction or removal, amend the report by submitting an amendment citing the original report number assigned according to paragraph (c)(1) of this ction, all of the information required by paragraph (c)(2), and any information required by paragraphs (c)(3) through (c)(12) of this ction that is different from the information submitted in the original report. The manufacturer or importer shall also provide a statement in accordance with paragraph (c)(13) of this ction for any required information that is not readily available.

(e) A report submitted by a manufacturer or importer under this ction (and any relea by FDA of that report or information) does not necessarily reflect a conclusion by the manufacturer, importer, or FDA that the report or information constitutes an admission that the device caud or contributed to a death or rious injury. A manufacturer or importer need not admit, and may deny, that the report or information submitted under this ction constitutes an admission that the device caud or contributed to a death or rious injury.

(f) No report of correction or removal is required under this part, if a report of the correction or removal is required and has been submitted under parts 803 or 1004 of this chapter.

[62 FR 27191, May 19, 1997, as amended at 63 FR 42232, Aug. 7, 1998; 69 FR 11311, Mar. 10, 2004; 78 FR 55821, Sept. 24, 2013]

Sec. 806.20 Records of corrections and removals not required to be reported.

(a) Each device manufacturer or importer who initiates a correction or removal of a device that is not required to be reported to FDA under 806.10 shall keep a record of such correction or removal.

(b) Records of corrections and removals not required to be reported to FDA under 806.10 shall contain the following information:

(1) The brand name, common or usual name, classification, name and product code if known, and the intended u of the device.

(2) The unique device identifier (UDI) of the device, or the device identifier, universal product code (UPC), model, catalog, or code number of the device and the manufacturing lot or rial number of the device or other identification number.

紫荆皮(3) A description of the event(s) giving ri to the information reported and the corrective or removal action that has been, and is expected to be taken.

(4) Justification for not reporting the correction or removal action to FDA, which shall contain conclusions and any followups, and be reviewed and evaluated by a designated person.

(5) A copy of all communications regarding the correction or removal.

(c) The manufacturer or importer shall retain records required under this ction for a period of 2 years beyond the expected life of the device, even if the manufacturer or importer has cead to manufacture or import the device. Records required to be maintained under paragraph (b) of this ction must be transferred to the new manufacturer or importer of the device and maintained for the required period of time.

[62 FR 27191, May 19, 1997, as amended at 63 FR 42233, Aug. 7, 1998; 78 FR 55821, Sept. 24, 2013]

Sec. 806.30 FDA access to records.

苹果双系统切换

Each device manufacturer or importer required under this part to maintain records and every person who is in charge or custody of such records shall, upon request of an officer or employee designated by FDA and under ction 704(e) of the act, permit such officer or employee at all reasonable times to have access to, and to copy and verify, such records and reports.

[63 FR 42233, Aug. 7, 1998]

Sec. 806.40 Public availability of reports.

(a) Any report submitted under this part is available for public disclosure in accordance with part 20 of this chapter.

(b) Before public disclosure of a report, FDA will delete from the report:

(1) Any information that constitutes trade cret or confidential commercial or financial information under 20.61 of this chapter; and

心率过低怎么治疗(2) Any personnel, medical, or similar information, including the rial numbers of implanted devices, which would constitute a clearly unwarranted invasion of personal privacy under 20.63 of this chapter or 5 U.S.C. 552(b)(6); provided, that except for the information under 20.61 of this chapter or 5 U.S.C. 552(b)(4), FDA will disclo to a patient who requests a report all the information in the report concerning that patient.

本文发布于:2023-07-09 06:23:02，感谢您对本站的认可！

本文链接：https://www.wtabcd.cn/fanwen/fan/82/1086857.html

上一篇：大气校正(ENVI)

下一篇：GE磁共振术语

标签：目标苹果题型逆商治疗年度双系统

留言与评论（共有 0 条评论）